Search research articles
Contact Us
Filters
Showing results (591-600 of 678) with videos related to
Page
of 68
Sort By:
Journal of Neurochemistry
|
October 13, 2005
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy
Günter U Höglinger, Annie Lannuzel, Myriam Escobar Khondiker, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 27, 2016
The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach
Johannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.
Sleep Medicine
|
January 14, 2021
microRNA signatures in prodromal REM sleep behavior disorder and early Parkinson's disease as noninvasive biomarkers
Ricardo Titze-de-Almeida, Simoneide Souza Titze-de-Almeida, Gabriel Ginani Ferreira, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2007
The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease
Günter U Höglinger, Joshua J Breunig, Candan Depboylu, et al.
Parkinsonism & Related Disorders
|
December 22, 2009
Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study
Yaroslav Winter, Sonja von Campenhausen, Georgy Popov, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
Pain in Parkinson's Disease: Current Concepts and a New Diagnostic Algorithm
Veit Mylius, Daniel Ciampi de Andrade, Rubens Gisbert Cury, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 18, 2023
Evaluation of a Structured Screening Assessment to Detect Isolated Rapid Eye Movement Sleep Behavior Disorder
Aline Seger, Anja Ophey, Wiebke Heitzmann, et al.
Revista De Neurologia
|
February 23, 2011
[Health-economic burden of Parkinson's disease in Portugal: a cohort study]
J P Reese, Y Winter, M M Rosa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 14, 2011
Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease
Andrew Lees, Stanley Fahn, Karla M Eggert, et al.
Pharmacoeconomics
|
August 16, 2005
Cost of illness and its predictors for Parkinson's disease in Germany
Annika E Spottke, Martin Reuter, Olaf Machat, et al.
Page
of 68
Search research articles
Search
Showing results (591-600 of 678) with videos related to
Sort By:
Page
of 68
Journal of Neurochemistry
|
October 13, 2005
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy
Günter U Höglinger, Annie Lannuzel, Myriam Escobar Khondiker, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 27, 2016
The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach
Johannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.
Sleep Medicine
|
January 14, 2021
microRNA signatures in prodromal REM sleep behavior disorder and early Parkinson's disease as noninvasive biomarkers
Ricardo Titze-de-Almeida, Simoneide Souza Titze-de-Almeida, Gabriel Ginani Ferreira, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2007
The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease
Günter U Höglinger, Joshua J Breunig, Candan Depboylu, et al.
Parkinsonism & Related Disorders
|
December 22, 2009
Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study
Yaroslav Winter, Sonja von Campenhausen, Georgy Popov, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
Pain in Parkinson's Disease: Current Concepts and a New Diagnostic Algorithm
Veit Mylius, Daniel Ciampi de Andrade, Rubens Gisbert Cury, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 18, 2023
Evaluation of a Structured Screening Assessment to Detect Isolated Rapid Eye Movement Sleep Behavior Disorder
Aline Seger, Anja Ophey, Wiebke Heitzmann, et al.
Revista De Neurologia
|
February 23, 2011
[Health-economic burden of Parkinson's disease in Portugal: a cohort study]
J P Reese, Y Winter, M M Rosa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 14, 2011
Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease
Andrew Lees, Stanley Fahn, Karla M Eggert, et al.
Pharmacoeconomics
|
August 16, 2005
Cost of illness and its predictors for Parkinson's disease in Germany
Annika E Spottke, Martin Reuter, Olaf Machat, et al.
Page
of 68